Trial
NCT00586716
Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Loma Linda University
Collaborators
—
Condition
End Stage Renal Disease
Intervention
intravenous immune globulin
Why stopped
Insufficient recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-09